Medical condition | Affected, No. (%) | Estimated daily productivity loss per person, mina | Estimated annual cost per person, $a | Estimated annual company cost, $a |
---|---|---|---|---|
Chronic back pain | 631 (4.3) | 16.7 (0.84) | 1 920 (98) | 1 210 000 (62 000) |
Mental illness | 44 (0.3) | 16.6 (3.28) | 2 100 (480) | 94 000 (21 000) |
General anxiety | 743 (5.1) | 16.2 (0.75) | 1 920 (93) | 1 430 000 (69 000) |
Migraines or severe headaches | 1 192 (8.2) | 14.7 (0.60) | 1 690 (70) | 2 020 000 (83 000) |
Neck pain | 477 (3.3) | 11.2 (0.68) | 1 290 (80) | 610 000 (38 000) |
Depression | 862 (5.9) | 9.9 (0.57) | 1 150 (66) | 990 000 (57 000) |
Autoimmune disease | 283 (1.9) | 9.5 (1.14) | 1 090 (130) | 310 000 (37 000) |
Arthritis | 1 124 (7.7) | 8.2 (0.42) | 930 (48) | 1 040 000 (54 000) |
Type I diabetes | 78 (0.5) | 6.5 (1.54) | 710 (170) | 56 000 (13 000) |
Any allergies (including seasonal) | 4 026 (27.6) | 6.2 (0.19) | 716 (23) | 2 880 000 (92 000) |
Respiratory (chronic bronchitis, emphysema, or sinusitis) | 186 (1.3) | 5.4 (0.88) | 630 (106) | 117 000 (20 000) |
Digestive disorder | 543 (3.7) | 5.3 (0.47) | 600 (54) | 327 000 (30 000) |
Pulmonary disease | 21 (0.1) | 4.1 (1.57) | 450 (170) | 10 000 (3 600) |
Any cancer | 285 (2.0) | 3.4 (0.61) | 410 (75) | 118 000 (21 000) |
Asthma | 1 017 (7.0) | 3.1 (0.26) | 350 (30) | 350 000 (31 000) |
Type II diabetes | 887 (6.1) | 2.4 (0.29) | 270 (33) | 244 000 (29 000) |
Seizure disorders | 59 (0.4) | 2.0 (0.87) | 240 (103) | 14 000 (6 000) |
Heart disease | 323 (2.2) | 2.0 (0.36) | 230 (42) | 75 000 (14 000) |
Other metabolic disease (thyroid, kidney/renal, liver) | 948 (6.5) | 1.6 (0.20) | 179 (23) | 169 000 (22 000) |
Hypertension (high blood pressure) | 3 208 (22.0) | 1.1 (0.09) | 126 (10) | 400 000 (33 000) |
Peripheral vascular disease | 38 (0.3) | 0.9 (0.41) | 90 (48) | 3 600 (1 800) |
Cerebrovascular disease/stroke | 34 (0.2) | 0.8 (0.36) | 90 (38) | 2 900 (1 300) |